Blue Crest Capital Management LTD Merck & Co., Inc. Transaction History

Blue Crest Capital Management LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $1.73 Million - $1.89 Million	-17,304 Reduced 41.84%	24,054 $2.62 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $3.23 Million - $3.59 Million	31,416 Added 315.99%	41,358 $4.26 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $1.08 Million - $1.18 Million	9,942 New	9,942 $1.15 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $156,625 - $217,091	-2,472 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $817,072 - $921,971	-10,532 Reduced 80.99%	2,472 $225,000
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $989,344 - $1.08 Million	13,004 New	13,004 $1.1 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $1.24 Million - $1.45 Million	-17,792 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $10.6 Million - $12.1 Million	-151,917 Reduced 89.52%	17,792 $1.48 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $8.12 Million - $9.42 Million	124,445 Added 274.93%	169,709 $13 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $1.11 Million - $1.31 Million	19,287 Added 74.25%	45,264 $3.21 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $3.47 Million - $4.07 Million	-68,222 Reduced 72.42%	25,977 $1.58 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $911,011 - $1.06 Million	17,877 Added 23.42%	94,199 $5.13 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $3.48 Million - $4.16 Million	67,443 Added 759.58%	76,322 $4.3 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $520,930 - $560,531	8,879	8,879 $569,000

3,819

1.87B

15.6M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $250B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.